or
forgot password
  • cancer clinical trials in oregon

  • Defibrotide for Patients With Hepatic Veno-occlusive Disease: A Treatment IND Study
    Oregon Health and Science University
    Portland, Oregon 97201
    Hepatic Veno-Occlusive Disease
    Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi
    Bend Memorial Clinic

    Trial Locations
    Bend Memorial Clinic
    Oregon Health & Science University
    Aspergillosis, Invasive Fungal Infections
    Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism
    Oregon Health Science University
    Portland, Oregon 97239
    Venous Thrombosis
    Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
    Clackamas Radiation Oncology Center

    Trial Locations
    Clackamas Radiation Oncology Center
    Legacy Mount Hood Medical Center
    Providence Milwaukie Hospital
    Providence Newberg Medical Center
    Willamette Falls Community Hospital
    Legacy Emanuel Hospital and Health Center
    Providence Portland Medical Center
    Legacy Good Samaritan Hospital and Medical Center
    Northwest Cancer Specialists-Rose Quarter Cancer Center
    Providence Saint Vincent Medical Center
    Columbia River Oncology Program
    Legacy Meridian Park Hospital
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Paclitaxel, Cisplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancer
    Providence Cancer Center at Providence Portland Medical Center

    Trial Locations
    Providence Cancer Center at Providence Portland Medical Center
    Providence St. Vincent Medical Center
    Esophageal Cancer
    Azacitidine and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
    Clackamas Radiation Oncology Center

    Trial Locations
    Clackamas Radiation Oncology Center
    Providence Milwaukie Hospital
    Providence Newberg Medical Center
    Providence Willamette Falls Medical Center
    Providence Portland Medical Center
    Providence Saint Vincent Medical Center
    Columbia River Oncology Program
    Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Erythroleukemia (M6a), Adult Pure Erythroid Leukemia (M6b), Secondary Acute Myeloid Leukemia, Untreated Adult Acute Myeloid Leukemia
    Safety Study of AP24534 to Treat Chronic Myelogenous Leukemia (CML) and Other Hematological Malignancies
    ARIAD Investigational Site #048
    Portland, Oregon 97239
    Chronic Myelogenous Leukemia, Hematologic Malignancies
    Mitoxantrone ± Cetuximab 2nd Line Androgen Independent Prostate Cancer (AIPC)
    Willamette Valley Cancer Center

    Trial Locations
    Willamette Valley Cancer Center
    Oregon Health & Science University
    Androgen-independent Prostate Cancer
    EZN-2285 or Pegaspargase and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
    Knight Cancer Institute at Oregon Health and Science University
    Portland, Oregon 97239-3098
    Leukemia
    Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
    Knight Cancer Institute at Oregon Health and Science University
    Portland, Oregon 97239-3098
    Kidney Cancer, Leukemia, Sarcoma, Unspecified Childhood Solid Tumor, Protocol Specific
    Axitinib (AG 013736) As Second Line Therapy For Metastatic Renal Cell Cancer
    Pfizer Investigational Site
    Eugene, Oregon 97401
    Kidney Neoplasms
    Capecitabine and Lapatinib With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB, Stage IIIC, or Stage IV Breast Cancer
    Clackamas Radiation Oncology Center

    Trial Locations
    Clackamas Radiation Oncology Center
    Providence Milwaukie Hospital
    Providence Newberg Medical Center
    Providence Willamette Falls Medical Center
    Providence Portland Medical Center
    Providence Saint Vincent Medical Center
    Columbia River Oncology Program
    HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy
    Clackamas Radiation Oncology Center

    Trial Locations
    Clackamas Radiation Oncology Center
    Bay Area Hospital
    Providence Milwaukie Hospital
    Providence Newberg Medical Center
    Providence Willamette Falls Medical Center
    Providence Portland Medical Center
    Providence Saint Vincent Medical Center
    Columbia River Oncology Program
    Salem Hospital
    Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Nilotinib and Imatinib Mesylate After Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia
    Oregon Health and Science University
    Portland, Oregon 97201
    Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Blastic Phase Chronic Myelogenous Leukemia, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Chronic Myelogenous Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Chronic Phase Chronic Myelogenous Leukemia, Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia, Philadelphia Chromosome Positive Childhood Precursor Acute Lymphoblastic Leukemia, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Lymphoblastic Leukemia, Relapsing Chronic Myelogenous Leukemia, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia
    Phase III Study of Docetaxel + Ramucirumab or Placebo in Breast Cancer
    ImClone Investigational Site
    Portland, Oregon 97239
    Breast Cancer
    Efficacy of XL184 (Cabozantinib) in Advanced Medullary Thyroid Cancer
    Oregon Health & Science University
    Portland, Oregon 97201
    Thyroid Cancer
    Phase II Lapatinib Plus Nab-Paclitaxel As First And Second Line Therapy In her2+ MBC
    GSK Investigational Site
    Oregon City, Oregon 97045
    Neoplasms, Breast
    To Evaluate Sipuleucel-T Manufactured With Different Concentrations of PA2024 Antigen
    Kaiser Permanente

    Trial Locations
    Kaiser Permanente
    Northwest Cancer Specialists
    Providence Medical Center
    Prostate Cancer